• Supports medical product development
  • Unique nuclear infrastructure
  • Supply of promising medical isotopes

FIELD-LAB: Are you stuck in the process of developing a new nuclear medicine? We may be the right partner to help you out.


Preclinical TRL 1-5
Preclinical TRL 1-5
Laboratory and animal testing to answer safety questions.
Medical Research
Clinical TRL 6
Clinical TRL 6
Tests on safety and dosage.
Phase 1
Clinical TRL 7
Clinical TRL 7
Phase II: Tests on efficacy and side effects. Phase III: Confirming research: testing of final dosage on usability and effectiveness.
Phase 2
Registration & Upscaling
Registration & Upscaling
Phase III (Registration & upscaling): Registration and market launch of new nuclear drug.
Phase 3


FIELD-LAB is a drug discovery facility that will help you to speed up the development and market launch of new nuclear drugs for cancer treatment. Through supply of small batches of radio chemicals and radio pharmaceuticals, we meet the need of Bio Pharma scientists and start-up ventures for research materials. This will drive both their ambitions to develop a new drug.

Nuclear infrastructure

FIELD-LAB has a unique and complete nuclear infrastructure.

  • High flux reactor
  • Radiological laboratories
  • Hot cell laboratories
  • GMP small scale production facility

Read more about Nuclear Infrastructure

Nuclear Infrastructure


Currently, research is done on the production and development of various isotopes:

  • Pb-212
  • Pt-195m CISSPECT
  • Lu-177 n.c.a.

Read more

Desklab 800X400

Projects we are proud of

  • High in demand medical isotope
  • Bèta-radiator
  • Independent supply by FIELD-LAB
View Product
  • High Quality
  • Chemotherapeutic drug (cisplatin) integrated with Pt-195m by synthesis
  • Chemotherapeutic function remains the same
View Product
  • Bèta radiator & single alpha emitting during decay
  • Ideal halflife (~10 hour)
  • Reliable supply
View Product

FIELD-LAB introduction video

Learn more about FIELD-LAB and its importance. Discover our global network for pre-clinical and clinical research: research that is part of the development of every new medical product.

  • Supply of radiochemical solutions and radiopharmaceuticals to laboratories
  • Both research and GMP grade
  • Creation of radiochemical processes using innovative isotopes
  • Collaboration between academic and industrial partners
  • Portal to a fast-growing network with an open innovation culture

Our partners

FIELD-LAB is created for and together with partners from different backgrounds. Some of the finest Dutch UMC’s have committed themselves to be part of this initiative. They believe in the beneficial results that will be brought to the Nuclear Medicine society. In addition, the partnerships that arise from FIELD-LAB form a portal to a fast growing network, which results in an open innovation environment.

Partners we work with

FIELD-LAB publications

02 July 2020


FIELD-LAB is the incubator for new nuclear medicines. Together with partners Field-LAB Developt new nuclear medicines for personalised treatment of cancer patients.

02 July 2020


The official launch of FIELD-LAB took place on February 6, 2019 in Petten. A unique collaboration to benefit a wide range of patients.


Karlijn Codee-van der Schilden

Get in touch

Karlijn Codee-van der Schilden
R&D Manager Medical Isotopes


Sander de Groot

Get in touch

Sander de Groot
Sr. Program Manager Medical Isotope Development